These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33839456)

  • 1. Role of AMPK and Akt in triple negative breast cancer lung colonization.
    Johnson J; Chow Z; Lee E; Weiss HL; Evers BM; Rychahou P
    Neoplasia; 2021 Apr; 23(4):429-438. PubMed ID: 33839456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer.
    Johnson J; Chow Z; Napier D; Lee E; Weiss HL; Evers BM; Rychahou P
    Cells; 2020 May; 9(5):. PubMed ID: 32438621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer.
    Gu X; Han S; Cui M; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
    Ann N Y Acad Sci; 2019 Jul; 1448(1):5-18. PubMed ID: 30900271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
    Chan SH; Kuo WH; Wang LH
    J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
    D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
    Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
    Cao W; Li J; Hao Q; Vadgama JV; Wu Y
    Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
    Humphries BA; Cutter AC; Buschhaus JM; Chen YC; Qyli T; Palagama DSW; Eckley S; Robison TH; Bevoor A; Chiang B; Haley HR; Sahoo S; Spinosa PC; Neale DB; Boppisetti J; Sahoo D; Ghosh P; Lahann J; Ross BD; Yoon E; Luker KE; Luker GD
    Breast Cancer Res; 2020 Jun; 22(1):60. PubMed ID: 32503622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
    Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
    Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
    You KS; Yi YW; Kwak SJ; Seong YS
    Int J Oncol; 2018 Mar; 52(3):828-840. PubMed ID: 29344641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.
    Huang SP; Liu PY; Kuo CJ; Chen CL; Lee WJ; Tsai YH; Lin YF
    J Hematol Oncol; 2017 Jun; 10(1):114. PubMed ID: 28576130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Akt3 signaling in triple-negative breast cancer.
    Chin YR; Yoshida T; Marusyk A; Beck AH; Polyak K; Toker A
    Cancer Res; 2014 Feb; 74(3):964-73. PubMed ID: 24335962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
    Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
    Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.
    Procopio C; Andreozzi F; Laratta E; Cassese A; Beguinot F; Arturi F; Hribal ML; Perticone F; Sesti G
    Endocrinology; 2009 Aug; 150(8):3584-93. PubMed ID: 19359389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.